Discovery Value Fund’s BeOne Medicines Ltd ONC Stock Holding History

Discovery Value Fund’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-26,863	Closed	-$3.29M	–	17
2019 Q3	$3.29M	Hold	26,863	–	–	0.36%	11
2019 Q2	$3.33M	Sell	26,863 -18,000	-40%	-$2.28M	0.38%	11
2019 Q1	$5.92M	Buy	44,863 +3,900	+10%	+$526K	0.66%	9
2018 Q4	$5.75M	Buy	+40,963	New	+$5.43M	0.85%	9

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Discovery Value Fund's ONC Position: Q4 2019 in Review

Discovery Value Fund sold out of BeOne Medicines Ltd (ONC) in Q4 2019, closing a stake of 26,863 shares — an estimated $3.29M sold.

Discovery Value Fund first reported a position in ONC in Q4 2018 and held it in 4 quarters. The position peaked at $5.92M in Q1 2019. 221 funds tracked by Wall St. Rank hold ONC as of Q4 2019.

Discovery Value Fund reported no remaining BeOne Medicines Ltd position as of Q4 2019 after selling out during the quarter.
Discovery Value Fund sold 26,863 BeOne Medicines Ltd shares in Q4 2019, an estimated $3.29M.
Discovery Value Fund first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 4 quarters.
Discovery Value Fund's BeOne Medicines Ltd position peaked at $5.92M in Q1 2019.
221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2019.

Based on Discovery Value Fund's 13F filing for Q4 2019, filed 13 Feb 2020.